Ischemic Stroke, Aortic Stenosis, Heart Failure with Complications Anemia and Hyponatremia
DOI:
https://doi.org/10.54783/influencejournal.v5i1.124Abstract
Ischemic stroke is a circulatory disorder in brain is caused by reduced or stopped blood flow in some areas of brain. Aortic stenosis is a heart valve disorder characterized by remodeling progressive fibro-calcification and thickening of the aortic valve leaflets over the years, evolves that occur in an early aortic valve (tricuspid) or an abnormal aortic valve (bicuspid) cause severe obstruction to cardiac outflow. Heart failure is a complex clinical syndrome that can occur as result of heart problem structural or functional impairment that impairs the ability of the ventricles to fill or secrete adequate amounts of blood to meet the metabolic demands of the tissues. The patient had a diagnosis of compensatory dyspnea et causa aortic stenosis, right hemiparesis, and repair aphasia delivered to the laboratory from neurorestoration room on January 9th, 2018 for a complete hematology and electrolyte examination (Na+,K+, Cl-).
References
. Lindman, B. R., Clavel, M. A., Mathieu, P., Iung, B., Lancellotti, P., Otto, C. M., & Pibarot, P. (2016). Calcific aortic stenosis. Nature reviews Disease primers, 2(1), 1-28.
. Cary, T., & Pearce, J. (2013). Aortic stenosis: pathophysiology, diagnosis, and medical management of nonsurgical patients. Critical care nurse, 33(2), 58-72.
. Lumbantobing, S. M. (2003). Circulatory Catastrophic Stroke in the Brain. Jakarta: FKUI.
. Messing, R. O. (2003). Nervous system disorder. New York: McGraw-Hill.
. Hankey, G. J. (2004). Your Questions Answered Stroke. London: Churchill Livingstone.
. Caplan, L. R., Liebeskind, D. S. (2016). Pathology, anatomy, and pathophysiology of stroke. In: Caplan's Stroke: A Clinical Approach. Cambridge University Press.
. Misbach, J. (2007). General views on stroke. Jakarta: Hall of Publishers FKUI.
. Misbach, J. (1999). General views on stroke. Jakarta: FKUI Publishing Center.
. Kurniasih, R., & Wijaya, A. (2002). Biochemical Markers for Stroke. Diagnostic Forum.
. Stroke, Ranked First Cause of Death in Indonesia. (2011). Retrieved from: pdpersi.co.id
. Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., ... & Sacco, R. L. (2006). Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke, 37(6), 1583-1633.
. Ross, R. (1999). Atherosclerosis—an inflammatory disease. New England journal of medicine, 340(2), 115-126.
. Libby, P. (2006). The pathogenesis of atherosclerosis. New York: McGraw-Hill.
. Smith, W. S., Johnston, S. C., & Easton, J. D. (2006). Cerebrovascular disease. New York: McGraw-Hill.
. Bath, P. M., & Lees, K. R. (2000). ABC of arterial and venous disease. Acute stroke BMJ, 320(7239), 920-923.
. Brott, T., & Bogousslavsky, J. (2000). Treatment of acute ischemic stroke. New England Journal of Medicine, 343(10), 710-722.
. Graham, S., & Hickey, R. (2002). Molecular pathology of stroke. Pittsburgh: American College of Neuropsychopharmacology.
. Fink, J., & Caplan, L. (2008). The importance of specific diagnosis in stroke patient management. Retrieved from: www.cambridge.org
. Misbach, J. (1999). Stroke diagnostics. Jakarta: FKUI Publishing House.
. Zimmermann-Ivol, C. G., Burkhard, P. R., Le Floch-Rohr, J., Allard, L., Hochstrasser, D. F., & Sanchez, J. C. (2004). Fatty acid binding protein as a serum marker for the early diagnosis of stroke: a pilot study. Molecular & Cellular Proteomics, 3(1), 66-72.
. Ali, M. S., Harmer, M., & Vaughan, R. (2000). Serum S100 protein as a marker of cerebral damage during cardiac surgery. British journal of anaesthesia, 85(2), 287-298.
. Ben Abdesselam, O., Vally, J., Adem, C., Foglietti, M. J., & Beaudeux, J. L. (2003). Reference values for serum S-100B protein depend on the race of individuals. Clinical chemistry, 49(5), 836-837.
. Missler, U., Wiesmann, M., Friedrich, C., & Kaps, M. (1997). S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke, 28(10), 1956-1960.
. Wunderlich, M. T., Ebert, A. D., Kratz, T., Goertler, M., Jost, S., & Herrmann, M. (1999). Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke, 30(6), 1190-1195.
. Büttner, T., Weyers, S., Postert, T., Sprengelmeyer, R., & Kuhn, W. (1997). S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke, 28(10), 1961-1965.
. Nash, D. L., Bellolio, M. F., & Stead, L. G. (2008). S100 as a marker of acute brain ischemia: a systematic review. Neurocritical care, 8, 301-307.
. Garbe, C., Leiter, U., Ellwanger, U., Blaheta, H. J., Meier, F., Rassner, G., & Schittek, B. (2003). Diagnostic value and prognostic significance of protein S‐100β, melanoma‐inhibitory activity, and tyrosinase/MART‐1 reverse transcription‐polymerase chain reaction in the follow‐up of high‐risk melanoma patients. Cancer: Interdisciplinary International Journal of the American Cancer Society, 97(7), 1737-1745.
. Butterworth, R. J., Wassif, W. S., Sherwood, R. A., Gerges, A., Poyser, K. H., Garthwaite, J., ... & Bath, P. M. W. (1996). Serum neuron-specific enolase, carnosinase, and their ratio in acute stroke: An enzymatic test for predicting outcome?. Stroke, 27(11), 2064-2068.
. Wu, Y. C., Zhao, Y. B., Lu, C. Z., Qiao, J., & Tan, Y. J. (2004). Correlation between serum level of neuron-specific enolase and long-term functional outcome after acute cerebral infarction: prospective study. Hong Kong Medical Journal, 10(4), 251-254.
. Foerch, C., Curdt, I., Yan, B., Dvorak, F., Hermans, M., Berkefeld, J., ... & Sitzer, M. (2006). Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. Journal of Neurology, Neurosurgery & Psychiatry, 77(2), 181-184.
. Herrmann, M., Vos, P., Wunderlich, M. T., de Bruijn, C. H., & Lamers, K. J. (2000). Release of glial tissue–specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke, 31(11), 2670-2677.
. Missler, U., Wiesmann, M., Wittmann, G., Magerkurth, O., & Hagenström, H. (1999). Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary clinical results. Clinical chemistry, 45(1), 138-141.
. Liswati, E. (2006). Protein S100B, neuron specific enolase (NSE), myelin basic protein (MBP), and heart-type fatty acid binding protein (H-FABP) as markers biochemistry for stroke. Diagnostic Forum, 1, 1-15.
. Pelsers, M. M., Hanhoff, T., Van der Voort, D., Arts, B., Peters, M., Ponds, R., ... & Glatz, J. F. (2004). Brain-and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility. Clinical chemistry, 50(9), 1568-1575.
. Jauch, E. C., Lindsell, C., Broderick, J., Fagan, S. C., Tilley, B. C., & Levine, S. R. (2006). Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke, 37(10), 2508-2513.
. Aleyasin, H., Rousseaux, M. W., Phillips, M., Kim, R. H., Bland, R. J., Callaghan, S., ... & Park, D. S. (2007). The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage. Proceedings of the National Academy of Sciences, 104(47), 18748-18753.
. Allard, L., BuRKHARD, P. R., Lescuyer, P., BuRGESS, J. A., Walter, N., Hochstrasser, D. F., & Sanchez, J. C. (2005). PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clinical chemistry, 51(11), 2043-2051.
. Utami, L. (2009). Biochemical Markers of Stroke. Cardio-Vascular Division Lecture Papers.
. Immanuel, S. (1020). The role of MR pro ADM and MR pro ANP as markers of heart failure. Clinical Pathology Continuing Education.
. Immanuel, S. (2014). Role of STL for heart failure. Clinical Pathology Continuing Education.
. Immanuel, S. (2016). Copeptin as a new marker of heart failure. Clinical Pathology Continuing Education.
. Adiyanti, S. S. (2016). Role of Galectin-3 as a marker of cardiac fibrosis. Clinical Pathology Continuing Education.
. Suryaatmadja, M. (2010). Update on examination of B-type natriuretic peptide (BNP and NT pro BNP) as a marker of heart failure. Education Ongoing Clinical Pathology.
. Francis, G. S., & Tang, W. H. W. (2004). Clinical evaluation of heart failure. Philadelphia: Elsevier Inc.
. Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., ... & Riegel, B. (2005). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult—summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Journal of the American College of Cardiology, 46(6), 1116-1143.
. Jackson, G., Gibbs, C. R., Davies, M. K., & Lip, G. Y. H. (2000). ABC of heart failure: Pathophysiology. BMJ: British Medical Journal, 320(7228), 167.
. Suryaatmadja, M. (2004). Recent developments in B-type natriuretic peptide (BNP) as biochemical markers of heart failure. Education Ongoing Clinical Pathology, 157-71.
. Ng, A. C., Kong, W. K., Kamperidis, V., Bertini, M., Antoni, M. L., Leung, D. Y., ... & Bax, J. J. (2015). Anaemia in patients with aortic stenosis: influence on long‐term prognosis. European Journal of Heart Failure, 17(10), 1042-1049.
. Caramelo, C., Just, S., & Gil, P. (2007). Anemia in heart failure: pathophysiology, pathogenesis, treatment, and incognitae. Revista Española de Cardiología (English Edition), 60(8), 848-860.
. Wirawan, R. (2012). Abnormalities of iron and heme metabolism in anemia. Clinical Pathology Continuing Education, 26-39.
. Suryadinata, R., Wirawan, R. (2009). Iron deficiency anemia confirmed by Ret-He. Jakarta: Department of Clinical Pathology FKUI.
. Moenadjat, Y., Madjid, A., Siregar, P., Wibisono, L. K., & Loho, T. (2007). Hyponatremia. In: Water-Electrolyte and Acid-Base Disorders. Jakarta: UPK-PKB.
. Verbrugge, F. H., Steels, P., Grieten, L., Nijst, P., Tang, W. W., & Mullens, W. (2015). Hyponatremia in acute decompensated heart failure: depletion versus dilution. Journal of the American College of Cardiology, 65(5), 480-492.
. Hoorn, E. J., & Zietse, R. (2017). Diagnosis and treatment of hyponatremia: compilation of the guidelines. Journal of the American Society of Nephrology, 28(5), 1340-1349.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 INFLUENCE: INTERNATIONAL JOURNAL OF SCIENCE REVIEW
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
